2B78.DE vs. LYPE.DE
Compare and contrast key facts about iShares Healthcare Innovation UCITS ETF (2B78.DE) and Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE).
2B78.DE and LYPE.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. 2B78.DE is a passively managed fund by iShares that tracks the performance of the iSTOXX® FactSet Breakthrough Healthcare. It was launched on Sep 8, 2016. LYPE.DE is a passively managed fund by Amundi that tracks the performance of the MSCI World Health Care. It was launched on Aug 19, 2010. Both 2B78.DE and LYPE.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: 2B78.DE or LYPE.DE.
Correlation
The correlation between 2B78.DE and LYPE.DE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
2B78.DE vs. LYPE.DE - Performance Comparison
Key characteristics
2B78.DE:
-0.43
LYPE.DE:
-0.59
2B78.DE:
-0.43
LYPE.DE:
-0.68
2B78.DE:
0.94
LYPE.DE:
0.90
2B78.DE:
-0.19
LYPE.DE:
-0.45
2B78.DE:
-1.01
LYPE.DE:
-1.39
2B78.DE:
7.06%
LYPE.DE:
6.38%
2B78.DE:
17.26%
LYPE.DE:
14.71%
2B78.DE:
-38.58%
LYPE.DE:
-25.95%
2B78.DE:
-31.28%
LYPE.DE:
-16.50%
Returns By Period
In the year-to-date period, 2B78.DE achieves a -12.32% return, which is significantly lower than LYPE.DE's -8.37% return.
2B78.DE
-12.32%
2.40%
-13.75%
-7.45%
-0.32%
N/A
LYPE.DE
-8.37%
-2.37%
-11.90%
-8.72%
4.95%
5.81%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
2B78.DE vs. LYPE.DE - Expense Ratio Comparison
2B78.DE has a 0.40% expense ratio, which is higher than LYPE.DE's 0.30% expense ratio.
Risk-Adjusted Performance
2B78.DE vs. LYPE.DE — Risk-Adjusted Performance Rank
2B78.DE
LYPE.DE
2B78.DE vs. LYPE.DE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF (2B78.DE) and Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
2B78.DE vs. LYPE.DE - Dividend Comparison
Neither 2B78.DE nor LYPE.DE has paid dividends to shareholders.
Drawdowns
2B78.DE vs. LYPE.DE - Drawdown Comparison
The maximum 2B78.DE drawdown since its inception was -38.58%, which is greater than LYPE.DE's maximum drawdown of -25.95%. Use the drawdown chart below to compare losses from any high point for 2B78.DE and LYPE.DE. For additional features, visit the drawdowns tool.
Volatility
2B78.DE vs. LYPE.DE - Volatility Comparison
iShares Healthcare Innovation UCITS ETF (2B78.DE) has a higher volatility of 11.53% compared to Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE) at 10.65%. This indicates that 2B78.DE's price experiences larger fluctuations and is considered to be riskier than LYPE.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.